Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 20:30 | 2026-03-30 | NUVL | Nuvalent, Inc. | Noci Darlene | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $97.81 | 5,500 | $537,942 | 58,117 | -8.6% |
| 2026-04-01 20:34 | 2026-04-01 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer; President & CEO | Pharmaceutical Preparations | SALE | $66.63 | 7,500 | $499,725 | 422,830 | -1.7% |
| 2026-04-01 20:05 | 2026-04-01 | ALT | Altimmune, Inc. | Durso Jerome Benedict | Director, Officer; President and CEO | Pharmaceutical Preparations | BUY | $3.14 | 15,000 | $47,100 | 47,500 | +46.2% |
| 2026-04-01 20:05 | 2026-04-01 | ALT | Altimmune, Inc. | WEAVER GREGORY L | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $3.15 | 10,000 | $31,499 | 38,078 | +35.6% |
| 2026-04-01 20:05 | 2026-03-30 | PVLA | PALVELLA THERAPEUTICS, INC. | JENKINS GEORGE M | Director | Pharmaceutical Preparations | BUY | $112.30 | 445 | $49,974 | 187,616 | +0.2% |
| 2026-04-01 13:31 | 2026-03-31 | TNXP | Tonix Pharmaceuticals Holding Corp. | LEDERMAN SETH | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | BUY | $12.62 | 5,000 | $63,100 | 20,001 | +33.3% |
| 2026-04-01 11:51 | 2026-03-31 | CRIS | CURIS INC | KAITIN KENNETH I | Director | Biological Products, (No Diagnostic Substances) | BUY | $0.55 | 10,000 | $5,487 | 11,407 | +710.7% |
| 2026-04-01 11:31 | 2026-03-31 | NSRX | Nasus Pharma Ltd | Teleman Dan Benjamin | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | BUY | $2.04 | 15,000 | $30,600 | 21,246 | +240.2% |
| 2026-03-31 20:10 | 2026-03-27 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | Officer; EVP and CMO | Pharmaceutical Preparations | SALE | $450.95 | 2,329 | $1,050,263 | 33,076 | -6.6% |
| 2026-03-31 20:25 | 2026-03-30 | ASMB | ASSEMBLY BIOSCIENCES, INC. | Bjorkquist Jeanette M | Officer; PFO and PAO | Pharmaceutical Preparations | SALE | $26.69 | 328 | $8,755 | 11,089 | -2.9% |
| 2026-03-31 20:15 | 2026-03-27 | MLYS | Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Pharmaceutical Preparations | BUY | $23.75 | 369,000 | $8,762,791 | 5,825,521 | +6.8% |
| 2026-03-31 20:13 | 2026-03-30 | INSM | INSMED Inc | Smith Michael Alexander | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $150.98 | 19,638 | $2,964,945 | 51,871 | -27.5% |
| 2026-03-31 20:10 | 2026-03-30 | PGEN | PRECIGEN, INC. | KIRK RANDAL J | Director, 10% owner | Pharmaceutical Preparations | SALE | $3.30 | 4,772,781 | $15,750,177 | 12,262,741 | -28.0% |
| 2026-04-01 01:30 | 2026-03-31 | COGT | Cogent Biosciences, Inc. | Fairmount Funds Management LLC | Director | Pharmaceutical Preparations | SALE | $34.66 | 7,000,000 | $242,620,000 | 5,503,418 | -56.0% |
| 2026-04-01 01:03 | 2026-03-31 | ABEO | ABEONA THERAPEUTICS INC. | Seshadri Vishwas | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $4.38 | 29,985 | $131,481 | 1,430,423 | -2.1% |
| 2026-04-01 00:14 | 2026-03-30 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | BUY | $18.91 | 54,000 | $1,021,140 | 1,726,039 | +3.2% |
| 2026-04-01 00:15 | 2026-03-27 | SLNO | SOLENO THERAPEUTICS INC | Huang Michael F. | Officer; Sr. VP of Clinical Development | Pharmaceutical Preparations | SALE | $30.44 | 6,582 | $200,365 | 39,823 | -14.2% |
| 2026-04-01 00:17 | 2026-03-27 | SLNO | SOLENO THERAPEUTICS INC | Manning Meredith | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $30.44 | 7,522 | $228,979 | 64,507 | -10.4% |
| 2026-03-31 23:33 | 2026-03-31 | EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | Officer; CMO | Pharmaceutical Preparations | OPT+S | $32.12 | 21,338 | $685,308 | 9,597 | -69.0% |
| 2026-03-31 22:56 | 2026-03-27 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Officer; President and COO | Biological Products, (No Diagnostic Substances) | OPT+S | $13.14 | 57,180 | $751,305 | 455,878 | -11.1% |
| 2026-03-31 22:44 | 2026-03-30 | PAHC | PHIBRO ANIMAL HEALTH CORP | BENDHEIM JACK | Director, Officer, 10% owner; President and CEO | Pharmaceutical Preparations | SALE | $53.75 | 14,080 | $756,834 | 38,120 | -27.0% |
| 2026-03-31 21:53 | 2026-03-06 | LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | Pharmaceutical Preparations | OPT+S | $200.76 | 2,161 | $433,842 | 30,724 | -6.6% |
| 2026-03-31 20:59 | 2026-03-30 | RZLT | Rezolute, Inc. | Evans Daron | Officer; CFO | Pharmaceutical Preparations | BUY | $2.85 | 10,000 | $28,500 | 414,462 | +2.5% |
| 2026-03-31 21:00 | 2026-03-31 | ZBIO | Zenas BioPharma, Inc. | Lu Hongbo | Director | Pharmaceutical Preparations | BUY | $20.00 | 75,000 | $1,500,000 | 422,968 | +21.6% |
| 2026-03-31 20:27 | 2026-03-30 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | Officer; Chief Operating Officer | Pharmaceutical Preparations | SALE | $28.19 | 10,000 | $281,857 | 159,914 | -5.9% |
| 2026-03-31 20:31 | 2026-03-27 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer; Chairperson & CEO | Pharmaceutical Preparations | OPT+S | $526.96 | 9,500 | $5,006,099 | 40,513 | -19.0% |
| 2026-03-31 20:31 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | CAUSEY CHRISTOPHER | Director | Pharmaceutical Preparations | OPT+S | $604.64 | 1,300 | $786,032 | 4,190 | -23.7% |
| 2026-03-31 20:32 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer; CFO AND TREASURER | Pharmaceutical Preparations | OPT+S | $593.17 | 10,000 | $5,931,683 | 18,876 | -34.6% |
| 2026-03-31 20:32 | 2026-03-30 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer; Chairperson & CEO | Pharmaceutical Preparations | OPT+S | $590.59 | 9,500 | $5,610,564 | 40,513 | -19.0% |
| 2026-03-31 20:35 | 2026-03-27 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% owner | Pharmaceutical Preparations | SALE | $4.89 | 100,997 | $494,017 | 431,094 | -19.0% |
| 2026-03-31 20:20 | 2026-03-30 | ASMB | ASSEMBLY BIOSCIENCES, INC. | White Nicole S | Officer; Chief Manufacturing Officer | Pharmaceutical Preparations | SALE | $26.69 | 197 | $5,258 | 37,477 | -0.5% |
| 2026-03-31 20:21 | 2026-03-31 | CYTK | CYTOKINETICS INC | Callos Andrew | Officer; EVP, Chief Commercial Officer | Pharmaceutical Preparations | SALE | $65.00 | 3,639 | $236,535 | 66,004 | -5.2% |
| 2026-03-31 20:05 | 2026-03-27 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.06 | 11,850 | $60,019 | 2,471,850 | +0.5% |
| 2026-03-31 11:11 | 2026-03-27 | IMNM | Immunome Inc. | SIEGALL CLAY B | Director, Officer; President and CEO | Pharmaceutical Preparations | BUY | $19.67 | 25,450 | $500,602 | 690,704 | +3.8% |
| 2026-03-30 21:29 | 2026-03-26 | XLO | Xilio Therapeutics, Inc. | Shannon James Samuel | Director | Pharmaceutical Preparations | BUY | $8.79 | 5,000 | $43,950 | 10,000 | +100.0% |
| 2026-03-31 01:01 | 2026-03-26 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Pharmaceutical Preparations | OPT+S | $27.45 | 70,000 | $1,921,500 | 42,963 | -62.0% |
| 2026-03-31 01:06 | 2026-03-25 | IBO | IMPACT BIOMEDICAL INC. | Macko Todd D | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $0.56 | 45,000 | $25,331 | 155,122 | -22.5% |
| 2026-03-31 00:30 | 2026-03-26 | WVE | Wave Life Sciences Ltd. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.23 | 8,772,496 | $54,624,578 | 26,975,505 | +48.2% |
| 2026-03-30 21:59 | 2026-03-27 | GILD | GILEAD SCIENCES, INC. | O'Day Daniel Patrick | Director, Officer; Chairman & CEO | Biological Products, (No Diagnostic Substances) | SALE | $136.82 | 10,000 | $1,368,162 | 642,567 | -1.5% |
| 2026-03-30 22:04 | 2026-03-26 | CGEN | COMPUGEN LTD | Levine Zurit | Officer; SVP, Business Development | Biological Products, (No Diagnostic Substances) | OPT+S | $2.04 | 11,875 | $24,187 | 29,375 | -28.8% |
| 2026-03-30 21:38 | 2026-03-26 | NGNE | Neurogene Inc. | Jordan Julie | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $21.89 | 828 | $18,128 | 12,472 | -6.2% |
| 2026-03-30 21:38 | 2026-03-26 | NGNE | Neurogene Inc. | McMinn Rachel | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $22.07 | 3,352 | $73,995 | 1,344,307 | -0.2% |
| 2026-03-30 21:38 | 2026-03-26 | NGNE | Neurogene Inc. | Cvijic Christine Mikail | Officer; President and CFO | Pharmaceutical Preparations | SALE | $21.62 | 2,558 | $55,316 | 103,240 | -2.4% |
| 2026-03-30 21:43 | 2026-03-26 | LQDA | Liquidia Corp | Bloch Stephen M | Director | Pharmaceutical Preparations | SALE | $36.08 | 70,234 | $2,533,769 | 2,188,935 | -3.1% |
| 2026-03-30 21:29 | 2026-03-26 | CYPH | CYPHERPUNK TECHNOLOGIES INC. | Mirabelli Christopher | Director | Pharmaceutical Preparations | SALE | $0.71 | 60,000 | $42,630 | 130,376 | -31.5% |
| 2026-03-30 21:29 | 2026-03-26 | SLXN | Silexion Therapeutics Corp | Shirvan Mitchell | Officer; CSO and CDO | Biological Products, (No Diagnostic Substances) | SALE | $1.36 | 22,818 | $31,032 | 27,889 | -45.0% |
| 2026-03-30 21:31 | 2026-03-26 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $98.73 | 5,500 | $542,991 | 59,634 | -8.4% |
| 2026-03-30 21:32 | 2026-03-27 | EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | Officer; CMO | Pharmaceutical Preparations | SALE | $30.98 | 16,358 | $506,735 | 9,597 | -63.0% |
| 2026-03-30 12:46 | 2026-03-27 | LENZ | LENZ Therapeutics, Inc. | Chevallard Daniel R. | Officer; Chief Financial Officer | Biological Products, (No Diagnostic Substances) | BUY | $8.57 | 7,500 | $64,275 | 12,886 | +139.2% |
| 2026-03-30 12:46 | 2026-03-27 | LENZ | LENZ Therapeutics, Inc. | Schimmelpennink Evert B. | Director, Officer; President, CEO and Secretary | Biological Products, (No Diagnostic Substances) | BUY | $8.95 | 28,089 | $251,411 | 77,289 | +57.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.